MBChB, BSc, DPhil, FRCS
Consultant Hepatobiliary Surgeon and Clinical Lecturer
Liver metastasis biology.
Radiomics for cancer prognostication.
Regulation of tumour immunity.
The cancer extracellular matrix.
I work as an NHS surgeon within the University of Oxford Hospitals NHS Foundation Trust. I chair the advanced colorectal cancer multidisciplinary team meeting held at the Churchill Hospital site. The focus of my practice is malignant and benign hepatobiliary pathology inclusive of:
Disappearing colorectal liver metastases in the era of state-of-the-art triple-modality diagnostic imaging.
Kuhlmann KF. et al, (2023), Eur J Surg Oncol
Long-term morbidity after surgery for perihilar cholangiocarcinoma: A cohort study.
Gilbert TM. et al, (2022), Surg Oncol, 45
Liquid biopsy in cholangiocarcinoma: Current status and future perspectives.
Rompianesi G. et al, (2021), World J Gastrointest Oncol, 13, 332 - 350
Cancer Extracellular Matrix Proteins Regulate Tumour Immunity.
Gordon-Weeks A. and Yuzhalin AE., (2020), Cancers (Basel), 12
Investigating immune microenvironment effects of radiotherapy in pre-clinical prostate cancer models
Philippou Y. et al, (2020), RADIOTHERAPY AND ONCOLOGY, 152, S1015 - S1015